tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
:VRAX
US Market
Advertisement

Virax Biolabs Group Ltd. Class A (VRAX) Income Statement

Compare
108 Followers

Virax Biolabs Group Ltd. Class A Income Statement

Last quarter (Q2 2025), Virax Biolabs Group Ltd. Class A's total revenue was $4.95K, an increase of Infinity% from the same quarter last year. In Q2, Virax Biolabs Group Ltd. Class A's net income was $-2.76M. See Virax Biolabs Group Ltd. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 6.33K$ 156.42K-$ 0.00$ 123.82K
Gross Profit
$ -53.07K$ 50.59K-$ 0.00$ -9.43K
Operating Expenses
$ 6.11M$ 6.55M$ 5.73M$ 1.73M$ 635.10K
Depreciation and Amortization
$ 343.39K$ 103.10K$ 0.00$ 1.73M$ 644.54K
EBITDA
$ -5.80M$ -6.61M$ -5.44M$ -750.00$ 0.00
Operating Income
$ -6.16M$ -6.50M$ -5.73M$ -1.73M$ -644.54K
Other Income/Expenses
$ -41.00K$ -242.65K$ 275.00K$ -16.19K$ -28.38K
Pretax Income
$ -6.20M$ -6.74M$ -5.46M$ -1.75M$ -672.91K
Net Income
$ -6.06M$ -6.73M$ -5.46M$ -1.71M$ -650.98K
Per Share Metrics
Basic EPS
$ -1.96$ -3.36$ -5.13$ -1.50$ -0.57
Diluted EPS
$ -1.95$ -3.36$ -5.13$ -1.50$ -0.57
Weighted Average Shares Outstanding
3.10M 2.01M 1.06M 1.14M 1.14M
Weighted Average Shares Outstanding (Diluted)
3.10M 2.01M 1.06M 1.14M 1.14M
Currency in USD

Virax Biolabs Group Ltd. Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis